WO1995028888A1 - A valvulotome - Google Patents

A valvulotome Download PDF

Info

Publication number
WO1995028888A1
WO1995028888A1 PCT/US1994/012468 US9412468W WO9528888A1 WO 1995028888 A1 WO1995028888 A1 WO 1995028888A1 US 9412468 W US9412468 W US 9412468W WO 9528888 A1 WO9528888 A1 WO 9528888A1
Authority
WO
WIPO (PCT)
Prior art keywords
bulb
cutting
distance
valvulotome
vein
Prior art date
Application number
PCT/US1994/012468
Other languages
French (fr)
Inventor
Inc. W.L. Gore & Associates
Eric D. Nelson
Original Assignee
Gore & Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gore & Ass filed Critical Gore & Ass
Priority to AU10848/95A priority Critical patent/AU1084895A/en
Publication of WO1995028888A1 publication Critical patent/WO1995028888A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/3207Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • A61B17/32075Pullback cutting; combined forward and pullback cutting, e.g. with cutters at both sides of the plaque
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22097Valve removal in veins

Definitions

  • This invention relates to the field of surgical devices used for vascular surgery and specifically for the disabling of venous valves.
  • proximal and distal are used herein to mean, respectively, nearer to or farther from the heart.
  • proximal and distal are used herein to mean, respectively, nearer to or farther from the heart.
  • ends of the device or components of the device as used in a living vein as the opposite ends of that vein are oriented with respect to the heart.
  • a rod is inserted through the distal incision and through the vein until it exits at the proximal incision.
  • a valve cutter is attached to the rod and a catheter is sutured to the valve cutter. The valve cutter is then drawn into the vein through the proximal incision. Fluid supplied by the catheter keeps the valve leaflets closed during the retrograde motion of the cutter through the vein from proximal to distal sites.
  • valvulotome An early commercially available valvulotome for the disruption of venous valves is the so-called "Mills retrograde valvulotome,” which consists of an elongated rod having an L-shaped end with a bulbous tip and a blade located between the bulbous tip and the elongated portion of the rod and facing in the direction of the elongated rod. The end of the valvulotome is passed through a valve and the instrument is then pulled in the reverse direction, causing the blade to cut through a valve leaflet. With this instrument, two or more passes are necessary for each valve set to insure that both valve leaflets are sufficiently destroyed to permit arterial flow of blood.
  • valvuloto es More recent designs of valvuloto es have evolved from work done by Dr. Peter Samuels into a form best described as a length of rod or cable having a pair of bulbs affixed to the proximal end of the rod or cable, the bulbs being separated by a relatively short length of the rod or cable. Both bulbs and the rod or cable share a common longitudinal axis.
  • the bulb at the very end of the rod or cable is commonly referred to as the cutting bulb and incorporates one or more cutting edges at the end of the cutting bulb opposite the extreme end of the device and closest to the other bulb, which is commonly referred to as the leading bulb.
  • the length of rod or cable with the attached pair of bulbs is inserted into a vein via an incision made to provide access to the distal end of the vein and inserted in the same direction as the normal flow of blood through the vein.
  • Both bulbs typically have tapered, pointed proximal ends so that they easily enter and pass through any venous valves encountered, the tapered, pointed bulb ends causing the valve to open around the passing bulbs.
  • the length of the rod or cable with the attached bulbs is then carefully withdrawn. The leading bulb then first encounters each valve.
  • This bulb having a distal end which is also tapered or pointed, again passes through the valve, this time in a direction opposite to that of normal blood flow through the vein.
  • the leading bulb holds the cutting bulb concentric within the vein with respect to the valve as a function of the respective diameters of the vein and the leading bulb.
  • the venous valve closes behind the leading bulb and around the short length of rod or cable connecting the two bulbs.
  • the cutting edge or edges of the cutting bulb encounter the valve and render the valve incompetent by preferably cutting the valve along its major axis while leaving the least possible amount of valve material attached to the luminal vein surface.
  • This result has been difficult to achieve consistently with presently available devices of this type without also cutting into the lumen of the vein and causing luminal damage.
  • This luminal damage to the vein primarily results from the cutting edge of the cutting bulb catching on tributaries to the vein or on the lumen of the vein as it tapers.
  • the space between the leading bulb and cutting bulb of commercially available two-bulb valvulotomes is excessive and that performance of the valvulotome is considerably improved and the risk of damage to the vein is reduced if the space between the two bulbs is less than or equal to 3.5 mm.
  • this distance should be greater than 1.15 m. This distance is measured from the apex of the cutting edge of the cutting bulb closest to the leading bulb, to the point of largest diameter of the leading bulb closest to the cutting bulb, that is, the point at which the diameter of the leading bulb begins to taper and therefore reduce.
  • Valvulotomes having this distance less tnan or equal to 3.5 mm considerably reduce the risk of the cutting edge inadvertently catching on a tributary vein or on the wall of the saphenous vein.
  • Figures 1A and IB describe side views of valvulotomes of the present invention.
  • Figure 2A describes a side view that defines distance D between the cutting edge and the leading bulb for a valvulotome having a leading bulb with tapered sides.
  • Figure 2B describes a side view that defines distance D between the cutting edge and the leading bulb for a valvulotome having a leading bulb with a rounded distal end.
  • Figure 3 describes a side view showing a method of quantitatively evaluating valve lysis.
  • Figure 1A describes a side view of a valvulotome 10 of the present invention having a leading bulb __l and a cutting bulb 1_4 attached to a length of rod or cable 20, typically a guidewire, at the proximal end 2_ ⁇ of the valvulotome 10.
  • the length of rod or cable £0 is most commonly in the form of a guidewire.
  • the two bulbs 12 and j_4 are typically connected by a short length of rod 18, all sharing a common longitudinal axis £6.
  • Leading bulb 12 has a maximum diameter _ ⁇ Z and a point 13 with respect to the longitudinal axis 26 which represents the point of closest proximity of maximum diameter 32 to the apex 16 of the cutting edge or edges of cutting bulb 14.
  • the present invention relates to the discovery that the effectiveness of a valvuloto e is related to this distance D between closest point 13 of the maximum diameter 2 of leading bulb 12 and the cutting edge or edges 16 of the cutting bulb 14 closest to the leading bulb 12.
  • Distance D is always measured parallel to the longitudinal axis 26 of the valvulotome ___[. It has been found that if this distance D is less than or equal to 3.5 mm, the effectiveness of the valvulotome is significantly increased.
  • Figure 1A describes a valvulotome having a cutting edge with multiple apexes .16 from which distance D is measured.
  • the cutting edge may be of circular form with only a single, continuous apex 16 as described by Figure IB. Distance D is measured from this single, continuous apex.
  • Figures 1A and IB describe valvulotomes TO having leading bulbs 12 with straight sides that are parallel to the common longitudinal axis 16 wherein leading bulb end nearest the cutting bulb tapers abruptly from its maximum diameter 32 as it approaches the cutting bulb.
  • Figure 2A describes a valvulotome having a leading bulb with a slight, gradual taper wherein the largest diameter 32 occurs at the end opposite the cutting bulb 14-
  • Figure 2B describes a valvulotome having a leading bulb with a rounded end nearest the cutting bulb 14.
  • the distance between the cutting edge of the cutting bulb closest to the leading bulb and the point of the effective largest diameter of the leading bulb closest to the cutting bulb is measured as described by Figures 2A and 2B.
  • distance D is measured along a first line 41 through the largest diameter of the cutting bulb 14 and parallel to the common longitudinal axis Z_ ⁇ .
  • Distance D extends from the cutting edge 1£ of the cutting bulb H that is closest to the leading bulb 1£, to a point A defined as follows.
  • Point A lies at the intersection of the first line 41 and a second line 43.
  • the second line 43 begins at point B defined by the intersection of the common longitudinal axis £6 and a third line 45 through and perpendicular to the common longitudinal axis £6 and through the at least one cutting edge 16 of the cutting bulb 14 closest to the leading bulb 12.
  • the second line 43 extends from point B through a tangent point T on the surface of leading bulb 12, wherein tangent point T is the closest possible tangent point to cutting bulb H-
  • tangent point T is the closest possible tangent point to cutting bulb H-
  • distance D is less than or equal to 3.0 mm and preferably less than or equal to 2.4 mm.
  • Distance D for a commercially available valvulotome having a leading bulb with a rounded distal end, a leather® 2 mm diameter valvulotome (Baxter Healthcare Corporation, Deerfield, IL; Catalog No.
  • CH8686-1 measures 3.2 mm by this method.
  • two stainless steel valvulotomes were made up using device geometries as shown by Figure 1A and described in further detail by PCT Publication Number W093/20764.
  • Leading bulbs 12 and cutting bulbs 14 were provided with female screw threads intended to mate with male screw threads at both ends of connecting rod 18.
  • Distance D was then adjustable according to the degree of engagement of the screw threads.
  • the two valvulotomes differed in that one was provided with a maximum leading bulb diameter of 2 mm while the other was 3 mm. The maximum diameter of the leading bulb was the same as the cutting bulb for both devices. Both devices were provided with cutting edges having four apexes and four recesses with the entire edge including apexes, recesses and points between being sharpened.
  • distance D less than or equal to 3.5 mm will also be effective for 4.0 mm and larger diameter valvulotomes.
  • Distance D was adjusted to various dimensions for both the 2 mm and 3 mm diameter valvulotomes.
  • the effectiveness of each valvulotome was tested on cryopreserved human veins at room temperature. The effectiveness was determined by noting the number of times that any cutting edge of the valvulotome caught at any point within the lumen of the vein other than at the attachment point of venous valves. Effectiveness was also measured by opening each vein longitudinally after valve lysis and measuring how much ridge of any lysed valve remained as shown by Figure 3.
  • Cryopreserved human veins were obtained from Northwest Tissue Center, Seattle WA. All veins had been obtained from donors 65 years of age or younger within 12 hours of death. Cryopreserved human vein has been found to substantially maintain the mechanical and physical properties of living human vein. No veins with a prior history of trauma, varicosity or infection were used. Veins having inside diameters from 2 to 6 mm and lengths between 25 and 45 cm were used. The number of venous valves per vein ranged from zero to five with three being typical.
  • a cryopreserved vein with Its proximal end marked was rewarmed 1n Lactated Ringer's Solution to room temperature and irrigated with the same solution containing 0.5% papaverine by volume. Extraneous tissue was dissected away and all side branches except the most proximal were ligated. Smaller veins were used with the 2.0 mm diameter valvulotome and larger veins were used with the 3.0 mm diameter valvulotome.
  • a second flushing catheter was connected to the remaining, most proximal tributary in order to provide a 100 mm Hg pressure head with the Lactated Ringer's Solution ensuring closure of the venous valves within the vein sample.
  • the proximal end of the vein was clamped off.
  • An inventive valvulotome was introduced to the vein sample distally and passed to the proximal end. The location of venous valves was noted during this procedure. After reaching the proximal end of the vein, the valvulotome was withdrawn by hand back toward the distal end of the vein while paying close attention to the force required to move the valvulotome through the vein and through venous valves as they were encountered by the cutting edge of the valvulotome.
  • any tendency for the valvulotome to hang up at any point in the vein other than at valves- was noted with particular attention paid to any increase in pulling force as the cutting edge of the valvulotome passed the point of attachment of each tributary of the vein. This tendency if any was recorded for each vein as a measure of the quality of valve lysis.
  • the flow of fluid from the pressure source out of the proximal end of the vein was noted as an indication of valve lysis.
  • a fiberscope was inserted into the vein from the distal end to confirm valve lysis. After removal of the fiberscope, the vein sample was cut open longitudinally for the entire length of the sample to allow inspection of valve lysis.
  • the degree of valve lysis was evaluated by sliding the pointed tip 52 of a pair of Potts Tenotomy scissors 54 (Part No. 640280, WECK Surgical Instruments, Largo, FL) along the luminal surface of the longitudinally opened vein £1n a direction 55 parallel to the length of the vein, from the proximal end 57 toward the distal end 52 with the tip pointed toward the distal end.
  • the scissors were held at an angle 5_5 of about 45° with respect to the luminal surface ⁇ fl of the vein 51 with the plane of the scissors handles 52 perpendicular to the luminal surface 5fi of the vein 51.
  • Veins were tested with the valvulotomes set at various bulb separation distances D as noted in Table 1.
  • the table describes the undistended inside diameter of each vein sample tested, distance D for the valvulotome, the number of valves encountered in the vein sample, the number of valves considered to have been lysed by the valvulotome, the remaining amount of valve ridge as encountered by the scissors tip and the number of times the valvulotome caught at any point within the lumen of the vein other than at valve attachment points (number of hang ⁇ ups). For vein sample No. 2, the remaining amount of valve ridge was not recorded.

Abstract

A valvulotome having a cutting bulb incorporating at least one cutting edge and a leading bulb wherein the cutting bulb and leading bulb are connected along their common longitudinal axes and wherein the bulbs are separated by a distance less than or equal to 3.5 mm. Preferably the distance is also greater than 1.15 mm.

Description

TITLE OF THE INVENTION
A VALVULOTOME
FIELD OF THE INVENTION
This invention relates to the field of surgical devices used for vascular surgery and specifically for the disabling of venous valves.
BACKGROUND OF THE INVENTION
The terms proximal and distal are used herein to mean, respectively, nearer to or farther from the heart. With respect to a valvuloto e, these describe ends of the device or components of the device as used in a living vein as the opposite ends of that vein are oriented with respect to the heart.
Arterial reconstruction involving an autologous saphenous vein is common in the field of peripheral vascular surgery in the lower extremities and in coronary bypass surgery. In peripheral vascular surgery, in situ bypass grafting has become more and more the operation of choice for bypassing the infrageniculate arteries and re¬ establishing arterial blood flow. The autogenous saphenous vein has also been shown historically to perform effectively as an artery in vascular cardiac bypass surgery. The earliest work with venous autogenous grafts was by Gluck in 1894, followed by Exner and Hopfner in 1903. In the United States, Julian et al., Lord and Stone, Dale et al., and Linton and Darling pioneered the wide use of an autologous vein in femoral-popliteal arterial reconstructive procedures. The concept of using the saphenous vein in situ is attributed to Karl Hall who suggested in 1959 that the saphenous vein bypass might improve if the vein were left in place and the valves were rendered incompetent. He was the first to successfully report the use of the in situ procedure as an arterial bypass in 1962. The technique of in situ bypass grafting was further augmented by Leather and Karmody who used valve strippers to disrupt the vein valves. With the increasing experience worldwide, it was apparent that the crux of the in situ vein graft was the method of removal of the valvular obstruction to distal arterial flow.
Leather described that it "has been found that the simplest, most expedient and least traumatic method of rendering the bicuspid venous valve incompetent is to cut the leaflets in their major axes while they were held in the functionally closed position by fluid flow or arterial pressure from above."
In order to accomplish this purpose, Leather stated that it is necessary to expose both proximal and distal sites of the vein. A rod is inserted through the distal incision and through the vein until it exits at the proximal incision. A valve cutter is attached to the rod and a catheter is sutured to the valve cutter. The valve cutter is then drawn into the vein through the proximal incision. Fluid supplied by the catheter keeps the valve leaflets closed during the retrograde motion of the cutter through the vein from proximal to distal sites.
An early commercially available valvulotome for the disruption of venous valves is the so-called "Mills retrograde valvulotome," which consists of an elongated rod having an L-shaped end with a bulbous tip and a blade located between the bulbous tip and the elongated portion of the rod and facing in the direction of the elongated rod. The end of the valvulotome is passed through a valve and the instrument is then pulled in the reverse direction, causing the blade to cut through a valve leaflet. With this instrument, two or more passes are necessary for each valve set to insure that both valve leaflets are sufficiently destroyed to permit arterial flow of blood.
More recent designs of valvuloto es have evolved from work done by Dr. Peter Samuels into a form best described as a length of rod or cable having a pair of bulbs affixed to the proximal end of the rod or cable, the bulbs being separated by a relatively short length of the rod or cable. Both bulbs and the rod or cable share a common longitudinal axis. The bulb at the very end of the rod or cable is commonly referred to as the cutting bulb and incorporates one or more cutting edges at the end of the cutting bulb opposite the extreme end of the device and closest to the other bulb, which is commonly referred to as the leading bulb. In use, the length of rod or cable with the attached pair of bulbs is inserted into a vein via an incision made to provide access to the distal end of the vein and inserted in the same direction as the normal flow of blood through the vein. Both bulbs typically have tapered, pointed proximal ends so that they easily enter and pass through any venous valves encountered, the tapered, pointed bulb ends causing the valve to open around the passing bulbs. After being passed through all of the venous valves which are intended to be rendered incompetent by this procedure, the length of the rod or cable with the attached bulbs is then carefully withdrawn. The leading bulb then first encounters each valve. This bulb, having a distal end which is also tapered or pointed, again passes through the valve, this time in a direction opposite to that of normal blood flow through the vein. The leading bulb" holds the cutting bulb concentric within the vein with respect to the valve as a function of the respective diameters of the vein and the leading bulb. As the rod is withdrawn, the venous valve closes behind the leading bulb and around the short length of rod or cable connecting the two bulbs. As the rod is continued to be withdrawn, the cutting edge or edges of the cutting bulb encounter the valve and render the valve incompetent by preferably cutting the valve along its major axis while leaving the least possible amount of valve material attached to the luminal vein surface. This result has been difficult to achieve consistently with presently available devices of this type without also cutting into the lumen of the vein and causing luminal damage. This luminal damage to the vein primarily results from the cutting edge of the cutting bulb catching on tributaries to the vein or on the lumen of the vein as it tapers.
SUMMARY OF THE INVENTION
According to the present invention, it has been discovered that the space between the leading bulb and cutting bulb of commercially available two-bulb valvulotomes is excessive and that performance of the valvulotome is considerably improved and the risk of damage to the vein is reduced if the space between the two bulbs is less than or equal to 3.5 mm. Preferably this distance should be greater than 1.15 m. This distance is measured from the apex of the cutting edge of the cutting bulb closest to the leading bulb, to the point of largest diameter of the leading bulb closest to the cutting bulb, that is, the point at which the diameter of the leading bulb begins to taper and therefore reduce. Valvulotomes having this distance less tnan or equal to 3.5 mm considerably reduce the risk of the cutting edge inadvertently catching on a tributary vein or on the wall of the saphenous vein.
BRIEF DESCRIPTION OF THE DRAWINGS
Figures 1A and IB describe side views of valvulotomes of the present invention. Figure 2A describes a side view that defines distance D between the cutting edge and the leading bulb for a valvulotome having a leading bulb with tapered sides. Figure 2B describes a side view that defines distance D between the cutting edge and the leading bulb for a valvulotome having a leading bulb with a rounded distal end. Figure 3 describes a side view showing a method of quantitatively evaluating valve lysis.
DETAILED DESCRIPTION OF THE INVENTION
Figure 1A describes a side view of a valvulotome 10 of the present invention having a leading bulb __l and a cutting bulb 1_4 attached to a length of rod or cable 20, typically a guidewire, at the proximal end 2_\ of the valvulotome 10. The length of rod or cable £0 is most commonly in the form of a guidewire. The two bulbs 12 and j_4 are typically connected by a short length of rod 18, all sharing a common longitudinal axis £6. Leading bulb 12 has a maximum diameter _\Z and a point 13 with respect to the longitudinal axis 26 which represents the point of closest proximity of maximum diameter 32 to the apex 16 of the cutting edge or edges of cutting bulb 14. The present invention relates to the discovery that the effectiveness of a valvuloto e is related to this distance D between closest point 13 of the maximum diameter 2 of leading bulb 12 and the cutting edge or edges 16 of the cutting bulb 14 closest to the leading bulb 12. Distance D is always measured parallel to the longitudinal axis 26 of the valvulotome ___[. It has been found that if this distance D is less than or equal to 3.5 mm, the effectiveness of the valvulotome is significantly increased.
Figure 1A describes a valvulotome having a cutting edge with multiple apexes .16 from which distance D is measured. Conversely, the cutting edge may be of circular form with only a single, continuous apex 16 as described by Figure IB. Distance D is measured from this single, continuous apex.
Figures 1A and IB describe valvulotomes TO having leading bulbs 12 with straight sides that are parallel to the common longitudinal axis 16 wherein leading bulb end nearest the cutting bulb tapers abruptly from its maximum diameter 32 as it approaches the cutting bulb. Figure 2A describes a valvulotome having a leading bulb with a slight, gradual taper wherein the largest diameter 32 occurs at the end opposite the cutting bulb 14- Figure 2B describes a valvulotome having a leading bulb with a rounded end nearest the cutting bulb 14. For valvulotomes of the types described by Figures 2A and 2B, the distance between the cutting edge of the cutting bulb closest to the leading bulb and the point of the effective largest diameter of the leading bulb closest to the cutting bulb is measured as described by Figures 2A and 2B. The distance, referred to in Figures 2A and 2B as distance D, is measured along a first line 41 through the largest diameter of the cutting bulb 14 and parallel to the common longitudinal axis Z_\. Distance D extends from the cutting edge 1£ of the cutting bulb H that is closest to the leading bulb 1£, to a point A defined as follows. Point A lies at the intersection of the first line 41 and a second line 43. The second line 43 begins at point B defined by the intersection of the common longitudinal axis £6 and a third line 45 through and perpendicular to the common longitudinal axis £6 and through the at least one cutting edge 16 of the cutting bulb 14 closest to the leading bulb 12. The second line 43 extends from point B through a tangent point T on the surface of leading bulb 12, wherein tangent point T is the closest possible tangent point to cutting bulb H- For example, if leading bulb H is asymmetrical about the common longitudinal axis 26 then it is important that the third line 45 extends through tangent point T which lies closest to cutting bulb. When distance D is determined by this method, distance D is less than or equal to 3.0 mm and preferably less than or equal to 2.4 mm. Distance D for a commercially available valvulotome having a leading bulb with a rounded distal end, a Leather® 2 mm diameter valvulotome (Baxter Healthcare Corporation, Deerfield, IL; Catalog No. CH8686-1), measures 3.2 mm by this method. To determine the effectiveness of different dimensions for distance D, two stainless steel valvulotomes were made up using device geometries as shown by Figure 1A and described in further detail by PCT Publication Number W093/20764. Leading bulbs 12 and cutting bulbs 14 were provided with female screw threads intended to mate with male screw threads at both ends of connecting rod 18. Distance D was then adjustable according to the degree of engagement of the screw threads. The two valvulotomes differed in that one was provided with a maximum leading bulb diameter of 2 mm while the other was 3 mm. The maximum diameter of the leading bulb was the same as the cutting bulb for both devices. Both devices were provided with cutting edges having four apexes and four recesses with the entire edge including apexes, recesses and points between being sharpened.
It is anticipated that a distance D less than or equal to 3.5 mm will also be effective for 4.0 mm and larger diameter valvulotomes. Distance D was adjusted to various dimensions for both the 2 mm and 3 mm diameter valvulotomes. For each chosen dimension for distance D, the effectiveness of each valvulotome was tested on cryopreserved human veins at room temperature. The effectiveness was determined by noting the number of times that any cutting edge of the valvulotome caught at any point within the lumen of the vein other than at the attachment point of venous valves. Effectiveness was also measured by opening each vein longitudinally after valve lysis and measuring how much ridge of any lysed valve remained as shown by Figure 3. - Cryopreserved human veins were obtained from Northwest Tissue Center, Seattle WA. All veins had been obtained from donors 65 years of age or younger within 12 hours of death. Cryopreserved human vein has been found to substantially maintain the mechanical and physical properties of living human vein. No veins with a prior history of trauma, varicosity or infection were used. Veins having inside diameters from 2 to 6 mm and lengths between 25 and 45 cm were used. The number of venous valves per vein ranged from zero to five with three being typical.
A cryopreserved vein with Its proximal end marked was rewarmed 1n Lactated Ringer's Solution to room temperature and irrigated with the same solution containing 0.5% papaverine by volume. Extraneous tissue was dissected away and all side branches except the most proximal were ligated. Smaller veins were used with the 2.0 mm diameter valvulotome and larger veins were used with the 3.0 mm diameter valvulotome.
A second flushing catheter was connected to the remaining, most proximal tributary in order to provide a 100 mm Hg pressure head with the Lactated Ringer's Solution ensuring closure of the venous valves within the vein sample. The proximal end of the vein was clamped off. An inventive valvulotome was introduced to the vein sample distally and passed to the proximal end. The location of venous valves was noted during this procedure. After reaching the proximal end of the vein, the valvulotome was withdrawn by hand back toward the distal end of the vein while paying close attention to the force required to move the valvulotome through the vein and through venous valves as they were encountered by the cutting edge of the valvulotome. Any tendency for the valvulotome to hang up at any point in the vein other than at valves- was noted with particular attention paid to any increase in pulling force as the cutting edge of the valvulotome passed the point of attachment of each tributary of the vein. This tendency if any was recorded for each vein as a measure of the quality of valve lysis. Following lysis of a valve, the flow of fluid from the pressure source out of the proximal end of the vein was noted as an indication of valve lysis. After removal of the valvulotome, a fiberscope was inserted into the vein from the distal end to confirm valve lysis. After removal of the fiberscope, the vein sample was cut open longitudinally for the entire length of the sample to allow inspection of valve lysis.
As shown by Figure 3, the degree of valve lysis was evaluated by sliding the pointed tip 52 of a pair of Potts Tenotomy scissors 54 (Part No. 640280, WECK Surgical Instruments, Largo, FL) along the luminal surface of the longitudinally opened vein £11n a direction 55 parallel to the length of the vein, from the proximal end 57 toward the distal end 52 with the tip pointed toward the distal end. The scissors were held at an angle 5_5 of about 45° with respect to the luminal surface ≤fl of the vein 51 with the plane of the scissors handles 52 perpendicular to the luminal surface 5fi of the vein 51. In this fashion, the pointed tip 52 of the scissors would catch on any appreciable ridge 50 of valve tissue remaining attached to the luminal surface ξ vein £ As the thickness the scissors tip £ including both blades of the scissors 54 was about 1.0 mm, it was possible to estimate the amount of valve ridge 60 remaining attached to the luminal surface __0 of the vein 51, if any. Both valve leaflets of each valve were measured in this fashion with the aid of 8X stereoscopic magnification. The largest amount of remaining ridge 60 so measured was recorded for each tested vein as an indication of lysis quality for that vein. The results for all veins tested for each of the 2 mm and 3 mm valvulotomes were recorded. Veins were tested with the valvulotomes set at various bulb separation distances D as noted in Table 1. The table describes the undistended inside diameter of each vein sample tested, distance D for the valvulotome, the number of valves encountered in the vein sample, the number of valves considered to have been lysed by the valvulotome, the remaining amount of valve ridge as encountered by the scissors tip and the number of times the valvulotome caught at any point within the lumen of the vein other than at valve attachment points (number of hang¬ ups). For vein sample No. 2, the remaining amount of valve ridge was not recorded. The data indicate that hang-ups did not occur when the bulb-separation was 3.5 mm or less, and that as indicated by the dimensions of remaining ridges and number of valves lysed, the inventive valvulotomes were quite effective. Only when the 2 mm diameter valvulotome was set at the extremely close bulb separation distance of 1.15 mm were any valves not sufficiently lysed by the valvulotome. -SI-
TABLE 1 EFFECTIVENESS OF VENOUS VALVULOTOMES
2 mm Diameter Valvulotome:
Vein ' Vein Valvulotome # Valves/ Ridge Number
Sample # Diameter Distance D # Valves Dimension of
(mm) Lysed (mm) Hang-Ups
1 2.5-3.0 4.40 mm 4/4 0-1 2
2 2.4 4.40 mm 0/0 N/R 1
3 2.8 4.40 mm 2/2 0 1
4 2.2-2.9 3.50 mm 3/3 0-0.5 0
5 2.55 3.50 mm 1/1 0 0
6 3.5 3.0 mm 1/1 0-0.5 0
7 2.7 3.0 mm 1/1 0 0
.8 2.7 3.0 mm 2/2 0-0.25 0
9 2.5 2.40 mm 2/2 0 0
10 1.9 2.40 mm 1/1 0+ 0
11 2.4 2.15 mm 3/3 0-1 0
12 2.8 1.90 mm 1/1 0 0
13 2.7 1.90 mm 2/2 0+ 0
14 2.5 1.90 mm 2/2 0-0.5 0
15 1.9 1.90 mm 3/3 0-0.75 0
16 2.5-3.0 1.40 mm 4/4 1-3 0
17 2.6 1.40 mm 1/1 0-1 0
18 2.2-2.9 1.15 mm 3/1 0-4 0
3 mm Diameter Valvulotome:
Vein Vein Val ulotome # Valves/ Ridge Number
Sample # Diameter Distance D # Valves Dimension of
(mm) Lysed (mm) Hang-Ups
19 3.0-3.5 4.52 mm 4/4 0-1 0
20 3.0-3.5 1.52 mm 3/3 0+ 0
21 2.9 1.52 mm 1/1 0-2.5 0
22 2.6 1.52 mm 3/3 0-0.25 0
23 2.4 1.27 mm 1/1 0-0.5 0

Claims

I Claim:
1. A valvulotome comprising a leading bulb having a maximum diameter and a cutting bulb having at least one cutting edge adjacent to the leading bulb wherein said leading bulb and said cutting bulb are connected along a common longitudinal axis and said leading bulb and said cutting bulb are separated by a distance from the maximum diameter of the leading bulb closest to the cutting bulb to the at least one cutting edge of the cutting bulb closest to the leading bulb, said distance being less than or equal to 3.5 mm.
2. A valvulotome according to claim 1 wherein said distance is greater than 1.15 mm.
3. A valvulotome according to claim 1 wherein said distance is less than or equal to 3.0 mm.
4. A valvulotome according to claim 3 wherein said distance is greater than 1.15 mm.
5. A valvulotome according to claim 1 wherein said distance is less than or equal to 2.4 mm.
6. A valvulotome according to claim 5 wherein said distance is greater than 1.15 mm.
7. A valvulotome according to claim 1 wherein said distance is less than or equal to 1.9 mm.
8. A valvulotome according to claim 7 wherein said distance is greater than 1.15 mm.
9. A valvulotome according to claim 1 wherein said distance is less than or equal to 1.4 mm.
10. A valvulotome according to claim 9 wherein said distance is greater than 1.15 mm.
11. A valvulotome according to claim 1 wherein said cutting edge is a circular cutting edge.
12. A valvulotome according to claim 1 wherein said cutting edge has at least two cutting points.
13. A valvulotome comprising a leading bulb and a cutting bulb having at least one cutting edge adjacent to the leading bulb wherein said leading bulb and said cutting bulb are connected along a common longitudinal axis, said valvulotome having a distance D between the at least one cutting edge of the cutting bulb closest to the leading bulb and a point A, wherein said distance D is measured along a first line through the largest diameter of the cutting bulb and parallel to the common longitudinal axis, wherein said distance D is less than or equal to 3.0 mm, and wherein point A is defined as the intersection of the first line and a second line, said second line beginning at a point B defined by the intersection of the common longitudinal axis and a third line through and perpendicular to the common longitudinal axis and through the at least one cutting edge of the cutting bulb closest to the leading bulb, said second line extending from said point B through a tangent point on the surface of said leading bulb, said tangent point being the closest possible tangent point to the cutting bulb.
14. A valvulotome according to claim 13 wherein said distance is greater than 1.15 mm.
15. A valvulotome according to claim 13 wherein said distance is less than or equal to 2.4 mm.
16. A valvulotome according to claim 15 wherein said distance is greater than 1.15 mm.
17. A valvulotome according to claim 13 wherein said cutting edge is a circular cutting edge.
18. A valvulotome according to claim 13 wherein said cutting edge has at least two cutting points.
PCT/US1994/012468 1994-04-25 1994-11-01 A valvulotome WO1995028888A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU10848/95A AU1084895A (en) 1994-04-25 1994-11-01 A valvulotome

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23288794A 1994-04-25 1994-04-25
US8/232,887940425 1994-04-25

Publications (1)

Publication Number Publication Date
WO1995028888A1 true WO1995028888A1 (en) 1995-11-02

Family

ID=22875005

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/012468 WO1995028888A1 (en) 1994-04-25 1994-11-01 A valvulotome

Country Status (2)

Country Link
AU (1) AU1084895A (en)
WO (1) WO1995028888A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016125A1 (en) * 1995-11-01 1997-05-09 W.L. Gore & Associates, Inc. A valvulotome
US7717930B2 (en) 2004-02-27 2010-05-18 Cook Incorporated Valvulotome with a cutting edge
US8398663B2 (en) 2004-02-27 2013-03-19 Cook Medical Technologies Llc Valvulotome device and method
US9782191B2 (en) 2014-01-21 2017-10-10 Cook Medical Technologies Llc Cutting devices and methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837345A (en) * 1973-08-31 1974-09-24 A Matar Venous valve snipper
US5139506A (en) * 1991-03-22 1992-08-18 Pilling Co. Valvulotome
WO1993020764A1 (en) * 1992-04-09 1993-10-28 Uresil Corporation Improved venous valve cutter

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837345A (en) * 1973-08-31 1974-09-24 A Matar Venous valve snipper
US5139506A (en) * 1991-03-22 1992-08-18 Pilling Co. Valvulotome
WO1993020764A1 (en) * 1992-04-09 1993-10-28 Uresil Corporation Improved venous valve cutter

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016125A1 (en) * 1995-11-01 1997-05-09 W.L. Gore & Associates, Inc. A valvulotome
US7717930B2 (en) 2004-02-27 2010-05-18 Cook Incorporated Valvulotome with a cutting edge
US8398663B2 (en) 2004-02-27 2013-03-19 Cook Medical Technologies Llc Valvulotome device and method
US9782191B2 (en) 2014-01-21 2017-10-10 Cook Medical Technologies Llc Cutting devices and methods
US10918408B2 (en) 2014-01-21 2021-02-16 Cook Medical Technologies Llc Cutting devices and methods

Also Published As

Publication number Publication date
AU1084895A (en) 1995-11-16

Similar Documents

Publication Publication Date Title
CA2131702C (en) Improved venous valve cutter for in-situ incision of venous valve leaflets
US5069679A (en) Method and apparatus for removing venous valves
US5092872A (en) Valvulotome catheter
Leather et al. A reappraisal of the in situ saphenous vein arterial bypass: its use in limb salvage
US4900300A (en) Surgical instrument
Acland Thrombus formation in microvascular surgery: an experimental study of the effects of surgical trauma
US4653496A (en) Transluminal lysing system
US20030055443A1 (en) Tripod knife for venous access
US5626578A (en) RF valvulotome
US4745919A (en) Transluminal lysing system
US5658301A (en) Self-centering valvulotome
US6887251B1 (en) Method and apparatus for vessel harvesting
JPS58500237A (en) microsurgical instruments
US20050245952A1 (en) Apparatus and method for dermal punch and follicular unit circumferential incision
US20060178677A1 (en) Hair punch
US7909762B2 (en) Vein harvesting system including dilator shaft and removable retractor housing
US5171316A (en) Valvulotome
WO1997016125A1 (en) A valvulotome
WO1995028888A1 (en) A valvulotome
Connolly In situ saphenous vein bypass: 1962 to 1987
Pederson et al. The distally-based radial forearm free flap with valvulotomy of the cephalic vein; a preliminary report
Dalsing et al. Angioscopic Valvulotomy: Evaluation of a New Miniaturized Prototype
RU2143236C1 (en) Device for fixing of great duodenal papilla during laser papillosphincterotomy
Leyser et al. Evaluation of a coronary lysing system: results of a preclinical safety and efficacy study
RU2309687C2 (en) Vascular instrument

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

WA Withdrawal of international application
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA